Endovascular

View the latest content related to this topic

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

Yael L. Maxwell

March 16, 2026

Slides

See all

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Presentation Miami Valves 2025

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

Presenter: Lourdes Villarrubia Varela

January 30, 2025

Presentation Miami Valves 2025

Something in the Way: An RV in Crisis

Presenter: Enrique Soltero Mariscal

January 30, 2025

Presentation Cardiovascular Interventions 2024

Building Your PERT Team: Designing the Right Team with the Right Technology

Presenter: Curtiss T. Stinis

November 11, 2024

News

See all

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

By Michael O'Riordan

March 20, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

By Yael L. Maxwell

March 16, 2026

News Daily News

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

By L.A. McKeown

March 06, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

By L.A. McKeown

March 04, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

By Michael O'Riordan

March 02, 2026

CRT 2026

March 7

March 10, 2026

THT 2026

March 2

March 04, 2026

EAPCI 2026

February 19

February 20, 2026

Videos on This Topic

See all

Video Interview

Advertisement

Endovascular

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Slides

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

Something in the Way: An RV in Crisis

Building Your PERT Team: Designing the Right Team with the Right Technology

News

What’s Going to Be Hot at ACC 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

CRT 2026: What to Expect in Washington, DC

TCTMD’s Top 10 Most Popular Stories for February 2026

More on This Topic

Conference Coverage

CRT 2026

THT 2026

EAPCI 2026

Videos on This Topic

Beyond the Data: How to Start a Successful PERT

Advertisement

Endovascular

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content